Nephros, Inc. (NASDAQ:NEPH) Short Interest Down 30.6% in November

Nephros, Inc. (NASDAQ:NEPH) was the target of a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 7,700 shares, a drop of 30.6% from the October 31st total of 11,100 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average trading volume of 11,200 shares, the short-interest ratio is currently 0.7 days.

Analyst Upgrades and Downgrades

Separately, Benchmark restated a “speculative buy” rating and set a $5.00 price objective on shares of Nephros in a research report on Tuesday, November 12th.

Institutional Trading of Nephros

A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP acquired a new position in Nephros, Inc. (NASDAQ:NEPH) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned approximately 0.17% of Nephros as of its most recent SEC filing. 41.10% of the stock is owned by institutional investors and hedge funds.

Nephros Stock Up 2.6 %

NASDAQ NEPH traded up $0.04 on Friday, reaching $1.55. The company had a trading volume of 219 shares, compared to its average volume of 14,875. The stock has a market capitalization of $16.34 million, a PE ratio of -17.22 and a beta of 1.19. The firm’s 50 day moving average price is $1.54 and its 200 day moving average price is $1.88. Nephros has a 12 month low of $1.36 and a 12 month high of $4.04.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.